Latest Articles

Publication Date
Add-on metformin promising in ER-positive endometrial cancer - University of Cincinnati

Add-on metformin promising in ER-positive endometrial cancer University of Cincinnati

Published: March 24, 2025, 5:05 p.m.
Exploratory Post Hoc Analysis of DUO-E Reveals Olaparib’s Benefit in Endometrial Cancer Subsets - The ASCO Post

Exploratory Post Hoc Analysis of DUO-E Reveals Olaparib’s Benefit in Endometrial Cancer Subsets The ASCO Post

Published: March 24, 2025, 2:03 p.m.
SGO 2025: Gaining Ground in the Treatment of Endometrial Cancer - Medscape

SGO 2025: Gaining Ground in the Treatment of Endometrial Cancer Medscape

Published: March 21, 2025, 7:05 p.m.
SGO 2025: Gaining Ground in Endometrial Cancer - Medscape

SGO 2025: Gaining Ground in Endometrial Cancer Medscape

Published: March 21, 2025, 7:05 p.m.
AI model detects endometrial cancer at almost 100 per cent accuracy - NT News

AI model detects endometrial cancer at almost 100 per cent accuracy NT News

Published: March 19, 2025, 3:45 p.m.
Canada Approves KEYTRUDA For Advanced Endometrial Cancer - Evrim Ağacı

Canada Approves KEYTRUDA For Advanced Endometrial Cancer Evrim Ağacı

Published: March 19, 2025, 2:55 p.m.
Investigational ADC Shows Promise in Advanced Endometrial Cancer - MSN

Investigational ADC Shows Promise in Advanced Endometrial Cancer MSN

Published: March 19, 2025, 1:18 a.m.
Investigational ADC Shows Promise in Advanced Endometrial Cancer - Medpage Today

Investigational ADC Shows Promise in Advanced Endometrial Cancer Medpage Today

Published: March 18, 2025, 8:07 p.m.
The Importance of Spotting Endometrial Cancer - Curetoday.com

The Importance of Spotting Endometrial Cancer Curetoday.com

Published: March 18, 2025, 3:24 p.m.
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups - OBR Oncology

Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups OBR Oncology

Published: March 18, 2025, 10:24 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!